Avalyn Pharma Inc. (AVLN)

Avalyn Pharma Inc. Statistics

Total Valuation

AVLN has a market cap or net worth of $628.07 million. The enterprise value is $491.38 million.

Market Cap	628.07M
Enterprise Value	491.38M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

AVLN has 36.95 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	36.95M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	14.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-57.23%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.67M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-91.29M
Pretax Income	-85.20M
Net Income	-85.20M
EBITDA	-93.69M
EBIT	-91.38M
Earnings Per Share (EPS)	-$2.31

Balance Sheet

The company has $138.36 million in cash and $1.67 million in debt, with a net cash position of $136.69 million or $3.70 per share.

Cash & Cash Equivalents	138.36M
Total Debt	1.67M
Net Cash	136.69M
Net Cash Per Share	$3.70
Equity (Book Value)	-238.66M
Book Value Per Share	-6.46
Working Capital	129.47M

Cash Flow

In the last 12 months, operating cash flow was -$81.48 million and capital expenditures -$344,000, giving a free cash flow of -$81.83 million.

Operating Cash Flow	-81.48M
Capital Expenditures	-344,000
Depreciation & Amortization	-2.31M
Net Borrowing	n/a
Free Cash Flow	-81.83M
FCF Per Share	-$2.21

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVLN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-13.57%
FCF Yield	-13.03%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a